JHOP Articles

Skip to main content

Review Article, Prostate Cancer

Comparison of Second-Generation Antiandrogens for the Treatment of Prostate Cancer

Seon Jo Park, PharmD, BCOP, Benjamin Yoder, PharmD, Tammy Li, PharmD

Seon Jo Park, PharmD, BCOP; Benjamin Yoder, PharmD; Tammy Li, PharmD

Case Reports, Leukemia, Adverse Events

Arsenic Trioxide–Induced QTc Interval Prolongation and the Potential Benefit of Beta-Blockers in Patients with Acute Promyelocytic Leukemia: Case Series

Nada Alsuhebany, BSPharmD, PharmD, BCOP; Marti Larriva, PharmD, BCPS, BCOP; Ali McBride, PharmD, MS, BCPS, BCOP, FASHP; Krisstina Gowin, DO

Original Research, Transplant

Impact of Letermovir for Cytomegalovirus Prophylaxis in High-Risk Patients Undergoing Allogeneic Hematopoietic Stem-Cell Transplantation

Brianna Archambeau, PharmD, BCOP, Ashley M. Leece, PharmD, BCOP, BCPS, Dhaval Patel, PharmD, BCOP, Chin Y. Liu, MS, PharmD, BCOP

Brianna Archambeau, PharmD, BCOP; Ashley M. Leece, PharmD, BCOP, BCPS; Dhaval Patel, PharmD, BCOP; Chin Y. Liu, MS, PharmD, BCOP

Original Research, Lymphoma, Immunotherapy, Infections, Monoclonal Antibodies

Hepatitis B Virus Infection Monitoring in Patients with Lymphoma Receiving Anti-CD20 Monoclonal Antibodies

Christopher Sinoimeri, PharmD, Bryan Do, PharmD, BCOP, Sheree Chen, PharmD, BCOP

Christopher Sinoimeri, PharmD; Bryan Do, PharmD, BCOP; Sheree Chen, PharmD, BCOP

ASCO Highlights, Bladder Cancer

Sacituzumab plus Pembrolizumab Shows Promising Antitumor Activity in Metastatic Urothelial Cancer

FDA Updates, Prostate Cancer

Pluvicto FDA Approved for PSMA-Positive Metastatic Prostate Cancer

ASCO Highlights, Prostate Cancer

Darolutamide plus ADT and Docetaxel Improves Survival in Men with Metastatic Hormone-Sensitive Prostate Cancer

ASCO Highlights, Prostate Cancer

Continuous Treatment with Enzalutamide and Docetaxel Reduces the Risk for Progression in Patients with Metastatic Castration-Resistant Prostate Cancer

FDA Updates, Lung Cancer, Checkpoint Inhibitors

Opdivo plus Platinum-Based Chemotherapy FDA Approved as First Neoadjuvant Treatment in Early-Stage NSCLC

FDA Updates, Breast Cancer

Lynparza Receives FDA Approval for Adjuvant Treatment of High-Risk Early Breast Cancer with BRCA Mutation

Page 55 of 199
Results 541 - 550 of 1986